全、新、优、品、好四大特点：

微管相关蛋白抗体说明书 全：公司提供上万种产品，涵盖了生物试剂，elisa试剂盒，标准品，培养基，原装耗材，抗体、培养基、ATCC细胞等，基本上各种科研所需产品在我司都能找到。

新：产品更新速度较快，基本上每周都有新产品出现。

优：产品质量好，投诉比较少。

好：我公司具有优质的技术团队，产品一旦售出，实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。

微管相关蛋白抗体说明书 英文名称  Anti-Tau protein

中文名称  微管相关蛋白抗体说明书 

别    名 MAPT; Microtuble-associted protein Tau; AI413597; AW045860; DDPAC; Disinhibition dementia parkinsonism amyotrophy complex; FLJ31424; FTDP 17; FTDP17; G Protein beta 1 gamma 2 subunit interacting factor 1; G protein beta1/gamma2 subunit interacting factor 1; MAPTL; MGC134287; MGC138549; MGC156663; Microtubule associated protein tau isoform 4; MSTD; Mtapt; MTBT1; MTBT2; Neurofibrillary tangle protein; Paired helical filament tau; PHF tau; PHF-tau; PPND; pTau; RNPTAU; Tauopathy and respiratory failure, included; TAU_HUMAN.

产品属性：

浓    度  1mg/1ml

规 格  0.1ml/100μg 0.2ml/200μg

抗体来源  Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat, Rabbit

产品类型   一抗  

研究领域    细胞生物 神经生物学 信号转导 细胞凋亡

蛋白分子量  predicted molecular weight: 83kDa 

性    状   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human Tau protein (705-729aa)

亚    型  IgG

纯化方法   affinity purified by Protein A

储 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

微管相关蛋白抗体说明书 产品应用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蜡切片需做抗原修复） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 Tau proteins are important Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by tau localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization. Tau proteins subcellular located in the axons of neurons, in the cytoso l and in association with plasma membrane components. It expressed in neurons. PNS-tau is expressed in the peripheral nervous system while the others are expressed in the central nervous system.

Function : Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.

Subunit : Interacts with PSMC2 through SQSTM. Interacts with SQSTM1 when polyubiquitinated. Interacts with FKBP4. Binds to CSNK1D. Interacts with SGK1.

Subcellular Location : Cytoplasm, cytosol. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm, cytoskeleton. Cell projection, axon. Note=Mostly found in the axons of neurons, in the cytosol and in association with plasma membrane components.

Tissue Specificity : Expressed in neurons. Isoform PNS-tau is expressed in the peripheral nervous system while the others are expressed in the central nervous system.

Post-translational modifications : Phosphorylation at serine and threonine residues in S-P or T-P motifs by proline-directed protein kinases (PDPK1: CDK1, CDK5, GSK3, MAPK) (only 2-3 sites per protein in interphase, seven-fold increase in mitosis, and in the form associated with paired helical filaments (PHF-tau)), and at serine residues in K-X-G-S motifs by MAP/microtubule affinity-regulating kinase (MARK1 or MARK2), causing detachment from microtubules, and their disassembly. Phosphorylation decreases with age. Phosphorylation within tau/MAP's repeat domain or in flanking regions seems to reduce tAU/MAP's interaction with, respectively, microtubules or plasma membrane components. Phosphorylation on Ser-610, Ser-622, Ser-641 and Ser-673 in several isoforms during mitosis. Phosphorylation at Ser-548 by GSK3B reduces ability to bind and stabilize microtubules. Phosphorylation at Ser-579 by BRSK1 and BRSK2 in neurons affects ability to bind microtubules and plays a role in neuron polarization. Phosphorylated at Ser-554, Ser-579, Ser-602, Ser-606 and Ser-669 by PHK. Phosphorylation at Ser-214 by SGK1 mediates microtubule depolymerization and neurite formation in hippocampal neurons. There is a reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces glycosylation by a factor of 2 and 4 respectively. Phosphorylation on Ser-721 is reduced by about 41.5% by GlcNAcylation on Ser-717.

Polyubiquitinated. Requires functional TRAF6 and may provoke SQSTM1-dependent degradation by the proteasome. PHF-tau can be modified by three different forms of polyubiquitination. 'Lys-48'-linked polyubiquitination is the major form, 'Lys-6'-linked and 'Lys-11'-linked polyubiquitination also occur.

O-glycosylated. O-GlcNAcylation content is around 8.2%. There is reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces O-GlcNAcylation by a factor of 2 and 4 respectively. O-GlcNAcylation on Ser-717 decreases the phosphorylation on Ser-721 by about 41.5%.

Glycation of PHF-tau, but not normal brain TAU/MAPT. Glycation is a non-enzymatic post-translational modification that involves a covalent linkage between a sugar and an amino group of a protein molecule forming ketoamine. Subsequent oxidation, fragmentation and/or cross-linking of ketoamine leads to the production of advanced glycation endproducts (AGES). Glycation may play a role in stabilizing PHF aggregation leading to tangle

DISEASE : Note=In Alzheimer disease, the neuronal cytoskeleton in the brain is progressively disrupted and replaced by tangles of paired helical filaments (PHF) and straight filaments, mainly composed of hyperphosphorylated forms of TAU (PHF-TAU or AD P-TAU). O-GlcNAcylation is greatly reduced in Alzheimer disease brain cerebral cortex leading to an increase in TAU/MAPT phosphorylations.

Defects in MAPT are a cause of frontotemporal dementia (FTD) [MIM:600274]; also called frontotemporal dementia (FTD), pallido-ponto-nigral degeneration (PPND) or historically termed Pick complex. This form of frontotemporal dementia is characterized by presenile dementia with behavioral changes, deterioration of cognitive capacities and loss of memory. In some cases, parkinsonian symptoms are prominent. Neuropathological changes include frontotemporal atrophy often associated with atrophy of the basal ganglia, substantia nigra, amygdala. In most cases, protein tau deposits are found in glial cells and/or neurons.

Defects in MAPT are a cause of Pick disease of the brain (PIDB) [MIM:172700]. It is a rare form of dementia pathologically defined by severe atrophy, neuronal loss and gliosis. It is characterized by the occurrence of tau-positive inclusions, swollen neurons (Pick cells) and argentophilic neuronal inclusions known as Pick bodies that disproportionally affect the frontal and temporal cortical regions. Clinical features include aphasia, apraxia, confusion, anomia, memory loss and personality deterioration.

Note=Defects in MAPT are a cause of corticobasal degeneration (CBD). It is marked by extrapyramidal signs and apraxia and can be associated with memory loss. Neuropathologic features may overlap Alzheimer disease, progressive supranuclear palsy, and Parkinson disease.

Defects in MAPT are a cause of progressive supranuclear palsy type 1 (PSNP1) [MIM:601104]; also abbreviated as PSP and also known as Steele-Richardson-Olszewski syndrome. PSNP1 is characterized by akinetic-rigid syndrome, supranuclear gaze palsy, pyramidal tract dysfunction, pseudobulbar signs and cognitive capacities deterioration. Neurofibrillary tangles and gliosis but no amyloid plaques are found in diseased brains. Most cases appear to be sporadic, with a significant association with a common haplotype including the MAPT gene and the flanking regions. Familial cases show an autosomal dominant pattern of transmission with incomplete penetrance; genetic analysis of a few cases showed the occurrence of tau mutations, including a deletion of Asn-613.

Defects in MAPT are a cause of Parkinson-dementia syndrome (PARDE) [MIM:260540]. A syndrome characterized by parkinsonism tremor, rigidity, dementia, ophthalmoparesis and pyramidal signs. Neurofibrillary degeneration occurs in the hippocampus, basal ganglia and brainstem nuclei.

Similarity : Contains 4 Tau/MAP repeats.

Database links : UniProtKB/Swiss-Prot: P10636.5

tau蛋白是脑内神经元细胞支架蛋白之一.其正常功能是促进微管蛋白组成微管,并维持已形成微管的稳定性.参与维持细胞形态、信息传递、细胞分裂等重要生物学过程,是轴突和神经元极性形成的不可缺少因素.

近年来发现tau蛋白与一些中枢变性疾病密切相关,尤其是神经Tau具有启动微管系统的装配以及稳定微管系统的作用，该蛋白的错误折叠与等神经退行性疾病密切相关.

实验流程：

正在热销的相关产品：

Angiotensin II receptor(Ang II ) 紧张素Ⅱ受体(抗原)Multi-class antibodies规格： 0.5mg

Anti-Phospho-Beta-Catenin (Ser552) 磷酸化β 连环素蛋白抗体Multi-class antibodies规格： 0.1ml

Rhesus antibody Rh PCDHGB1 原钙粘蛋白γB1抗体 规格 0.2ml

IL12B Kit Human 人 IL12B / NKSF2 / p40 ELISA配对抗体 ELISA

TRAP80 英文名称： MED17抗体 0.2ml

phospho-CBL2 (Tyr731) 英文名称： 磷酸化原癌蛋白CBL2抗体 0.1ml

Anti-Phospho-Beta-Catenin (Ser552) 磷酸化β 连环素蛋白抗体Multi-class antibodies规格： 0.1ml

ACTH ELISA Kit 大鼠促肾上腺皮质激素Multi-class antibodies规格： 48T

Anti-AT1R/FITC 荧光素标记紧张素Ⅱ-1型受体抗体IgGMulti-class antibodies规格： 0.2ml

Rhesus antibody Rh FAIM3 FAS凋亡抑制分子3抗体 规格 0.2ml

BMG/ Beta2-MG ELISA Kit 大鼠β2微球蛋白 96T

M2-PK (pyruvate Kinase M2) 英文名称： 酸激酶-M2 0.1ml

ADH5 英文名称： 乙醇脱氢酶5抗体 0.2ml

Anti-AT1R/FITC 荧光素标记紧张素Ⅱ-1型受体抗体IgGMulti-class antibodies规格： 0.2ml

Anti-SLC40A1/FPN1/FITC 荧光素标记细胞膜铁转运蛋白SLC40A1抗体IgGMulti-class antibodies规格： 0.2ml

Calponin 1 钙调节蛋白-1(抗原)Multi-class antibodies规格： 0.5mg

原癌基因抗体 Anti-N-ras 0.1ml

Synaptotagmin X 英文名称： 突触结合蛋白10抗体 0.2ml

EVC2 英文名称： 膜蛋白EVC2抗体 0.1ml

Rhesus antibody Rh phospho-p23 (Ser113) 磷酸化端粒酶结合蛋白P23抗体 规格 0.1ml

Calponin 1 钙调节蛋白-1(抗原)Multi-class antibodies规格： 0.5mg

大鼠尿激酶型纤溶酶原激活物受体(PLAUR/uPAR)ELISA试剂盒 ，英文名： PLAUR/uPAR ELISA Kit

人干扰素诱导蛋白10(IP-10/CXCL10)ELISA检测试剂盒Humanierferon-inducibleprotein10,IP-10ELISAKit 96T/48T

鱼酚氧化酶(PO)免疫试剂盒 Fish phenol oxidase,PO ELISA Kit

CLIAKitforPCT(MouseProcalcitonin)ELISAKit小鼠降钙素原规格：48T/96T

树脂法骨DNA萃取试剂盒20次

ELISAKitC3b人补体片断3b规格：48T/96T

大鼠促甲状腺激素(TSH)ELISA 试剂盒 96T/48T 试剂盒 组装/原装

人免疫球蛋白轻链lambda(λ-IgLC)免疫试剂盒 Human lambda immunoglobulin light chain,λ-IgLC ELISA Kit

MouseoponinⅠ,Tn-ⅠELISAKit小鼠肌钙蛋白Ⅰ(Tn-Ⅰ)ELISA试剂盒规格：96T/48T

羟脯氨酸(HYP)终点比色法定量检测试剂盒50次

Humanpro-gasin-releasingpeptide,ProGRPELISA试剂盒人胃泌素释放肽前体(ProGRP)ELISA试剂盒规格：96T/48T

Humahrombieceptor,ELISAKit人凝血酶受体()ELISA试剂盒规格：96T/48T

微管相关蛋白抗体说明书 大鼠法尼基二磷酸合酶(FDPS)ELISA试剂盒 ，英文名： FDPS ELISA Kit

Rat ierleukin 1 (IL-1) ELISA Kit 大鼠白介素1(IL-1)ELISA试剂盒

RatThrombopoietin,TPOELISAkit 大鼠血小板生成素(TPO)ELISA试剂盒 96T/48T 进口分装

CLIAKitforDHEA-S7(HumanDehydroepiandrosteroneS7)ELISAKit人脱氢表雄同S7规格：48T/96T

细胞溶酶体脂酶(酸性脂酶)活性比色法定量检测试剂盒20次

RatGrowthHormoneReleasingPeptide,GHRPELISAKit大鼠生长激素释放多肽(GHRP)ELISA试剂盒规格：96T/48T

技术外包服务:

★微管相关蛋白抗体说明书 分子生物学：质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学：基因合成、引物合成、基因测序、载体构建等

★蛋白工程：原核、哺乳动物蛋白表达系统等

★病毒包装：腺病毒、慢病毒等

★抗体工程：磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★细胞工程：细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。